[New European approvals: Durvalumab - In first line metastatic small-cell lung cancer].

[New European approvals: Durvalumab - In first line metastatic small-cell lung cancer]. Bull Cancer. 2020 Nov 10;: Authors: El Kaddissi A, Basse C PMID: 33187682 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33187682?dopt=Abstract

Source: Bulletin du Cancer - November 10, 2020 Category: Cancer & Oncology Authors: El Kaddissi A, Basse C Tags: Bull Cancer Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer